ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 57

Age, Gender, Racial and Comorbidity Differences Among Systemic Lupus Erythematosus Patients Hospitalized with Ischemic Stroke Compared to the General Population: A Nationwide Analysis

Tapan Mehta1, Khushboo Sheth2, Ronak Soni3, Vishad Sheth4, Kathan Mehta5 and Christopher Scola6, 1Neurology, University of Connecticut, Farmington, CT, Farmington, CT, 2Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, 3Central Michigan University, Mount Pleasant, MI, 4Mercy Catholic Medical Center, Yeadon, PA, 5Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA, 6Rheumatology, Hartford Hospital, Hartford, CT

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Comorbidity, race/ethnicity and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Epidemiology and Public Health Poster I: Comorbidities and Outcomes of Systemic Inflammatory Diseases

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To determine if age, gender and racial discrepancies exist, and to determine the occurence of comorbidities among patients hospitalized with ischemic stroke with Systemic Lupus Erythematosus (SLE) in comparison to the general population.

Methods: We queried the Healthcare Cost and Utilization Project’s (HCUP) Nationwide Inpatient Sample (NIS) between 2004 and 2010 and separated the hospitalizations due to or with ischemic stroke using ICD 9 diagnostic codes previously established by HCUP. Among this population, we identified the patients with SLE and calculated the average age of patients with and without SLE at the time of hospitalization for ischemic stroke. In addition, we calculated the gender and racial distribution of occurrence of ischemic stroke among SLE patients compared to the general population using the above database. We also looked at the Charlson comorbidity index (CCI) among these populations. Using SAS 9.2, survey procedures were used to identify univariate predictors of ischemic stroke.

Results: A total of 790,912 (weighted N=3,900,707) patients who were hospitalized with ischemic stroke were available for analysis out of which 3428 (weighted N= 16,828) had SLE. On univariate analysis, the average age of ischemic stroke in the general population was 70.9+_0.02 years, whereas in the SLE population, the average age of ischemic stroke was 56.5+-0.30 years (p<0.0001). Among the general population, 53.61% of all ischemic stroke population was females; whereas among the SLE population, 85.98% of the population was females (p<0.0001). Of the general ischemic stroke population, 55.7% were white, 22.6% were black and 21.7% belonged to other races. Among the SLE population, 44.9% were white, 35.6% were black and 19.5% belonged to other races (p<0.0001). The average CCI for the SLE population was 3.48+-0.03 compared to 2.67+-0.00 among the general population (p<0.0001).

Conclusion: There are significant discrepancies in age, gender and racial distribution among patients with SLE hospitalized with ischemic stroke compared to the general population. Patients with SLE are at increased risk of stroke approximately 13 years before the general population. The preponderance of  SLE among female patients explains the increased incidence of ischemic stroke in females compared to the general population. Higher proportion of African American patients with SLE was hospitalized with ischemic stroke compared to the general population. The higher CCI is elucidated by the fact that SLE is a multisystemic disease, thus increasing the risk for comorbidities.


Disclosure: T. Mehta, None; K. Sheth, None; R. Soni, None; V. Sheth, None; K. Mehta, None; C. Scola, None.

To cite this abstract in AMA style:

Mehta T, Sheth K, Soni R, Sheth V, Mehta K, Scola C. Age, Gender, Racial and Comorbidity Differences Among Systemic Lupus Erythematosus Patients Hospitalized with Ischemic Stroke Compared to the General Population: A Nationwide Analysis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/age-gender-racial-and-comorbidity-differences-among-systemic-lupus-erythematosus-patients-hospitalized-with-ischemic-stroke-compared-to-the-general-population-a-nationwide-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-gender-racial-and-comorbidity-differences-among-systemic-lupus-erythematosus-patients-hospitalized-with-ischemic-stroke-compared-to-the-general-population-a-nationwide-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology